Current location - Plastic Surgery and Aesthetics Network - Plastic surgery and beauty - Leading stocks in medical consumption sector
Leading stocks in medical consumption sector
Leading stocks in medical consumption sector

Are you also looking for information about leading stocks in the medical consumption sector? That's right. Bian Xiao has carefully compiled this article about the leading stocks in the medical consumption sector, which should be able to answer your doubts. More information about leading stocks in medical consumption sector can be searched in the upper right corner.

Leading stocks in medical consumption sector

The leading stocks in the medical consumption sector are:

1. Ha Sanlian: The company is a high-tech enterprise engaged in pharmaceutical manufacturing, and its products include chemical raw materials, chemical preparations, Chinese patent medicines, Chinese herbal pieces and so on.

2. Harbin Pharmaceutical Co., Ltd.: The company is a pharmaceutical enterprise with a history of more than 50 years. Its products include oral liquid, syrup, tablets, capsules, granules and pills.

3. Tibet Pharmaceutical: The company's main business is drug research and development, production and sales. The main products are antibiotics, cardiovascular, anti-tumor, digestive system, respiratory system, nervous system, anti-virus and so on.

4. Saisheng Pharmaceutical: The company is a high-growth pharmaceutical enterprise with generic drugs as the mainstay and innovative drugs as the supplement.

5. Southwest Synthesis: The company's main business is research and development, production and sales of chemical raw materials and preparation products.

6. Changjiang Health: The company's main business is research and development, production and sales of pharmaceutical products. The main products include chemical synthetic drugs and plant extract drugs.

7. Encyclopedia Biology: The company's main business is research and development, production and sales of vaccines. The main products include human vaccines and animal vaccines.

8. Rheinland Bio: The company is a company engaged in research and development, production and sales of natural plant extracts.

9. Tibet Pharmaceutical: The company is a high-tech enterprise engaged in pharmaceutical manufacturing, and its products include antibiotics, cardiovascular, anti-tumor, digestive system, respiratory system, nervous system and antivirus.

10. Guizhou Bailing: The company is a large-scale pharmaceutical listed company integrating R&D, Miao medicine production and sales.

1 1. Angel Pharmaceutical: The company is an enterprise engaged in the research, development, production and sales of traditional Chinese medicine.

12. Qianjin Pharmaceutical: The company is mainly engaged in the production and sales of pediatric drugs, gynecological drugs, antibiotics and other drugs.

13. Jiang Zhong Pharmaceutical Co., Ltd.: The company is a large-scale pharmaceutical listed company integrating drug research and development, production and sales.

14. Ling Rui pharmaceutical co., ltd is an enterprise engaged in drug research, development, production and sales.

15. Jianmin group: the company's main business is drug research and development, production and sales. The main products include medicines and medical devices.

16. Xinlitai: The company is an enterprise engaged in research and development, production and sales of pharmaceutical products. The main products include cardiovascular, anti-infection and metabolic drugs.

17. China resources Sanjiu: the company is a leading enterprise in the high-end medical and health field in China, mainly engaged in prescription drugs, health care products and medical and health services.

18. Kunyao Group: The company is an enterprise engaged in R&D and production of active ingredients and key intermediates of natural medicines.

19. Jiang Zhong Pharmaceutical Co., Ltd.: The company is a large-scale pharmaceutical listed company integrating drug research and development, production and sales.

20. New Cape: The company is a well-known provider of information solutions for smart hospitals in China, focusing on providing core software and hardware products and solutions for medical digitalization.

2 1.00000 bond: The company's main business is research and development, production and sales of Chinese patent medicines and chemical medicines for cardiovascular and cerebrovascular diseases.

22. Tonghua Jinma: The company's main business is research and development, production and sales of chemical raw materials and preparation products.

23. Shuangcheng Pharmaceutical Co., Ltd. is an enterprise specializing in the research, development, production and sales of chemical synthetic peptides drugs.

24. Ha Sanlian: The company is a high-tech enterprise engaged in pharmaceutical manufacturing, and its products include chemical raw materials, chemical preparations, Chinese patent medicines, Chinese herbal pieces, etc.

Leading stock in medical consumption industry

The leading stocks in the medical consumption industry are:

_ _ Harbin Sanlian (0028 15): The company signed an exclusive promotion agreement with ArborPharmaceuticalsGroup, LLC of the United States (hereinafter referred to as Arbor Pharmaceuticals).

_ _ Harbin Pharmaceutical Co., Ltd. (600664): The company signed an agreement with Pfizer to obtain the exclusive and non-exclusive promotion right of Zostavax.

_ _ China Resources Shuanghe (600062): The company signed an agreement with Pfizer to obtain the exclusive and non-exclusive promotion rights of Xgeva drugs.

_ _ Jiuzhoutong (600558): medical equipment faucet.

_ _ New Cape (300248): New Cape serves key business scenarios such as hospitals and laboratories with automatic intelligent data acquisition and control products and solutions. Based on a deep understanding of the hospital's core business processes, it is business-oriented and data-centered, and provides hospitals with all-round digital services such as clinical path optimization, smart logistics, smart materials, smart medical records and medical safety through digital platforms.

These are just some leading stocks in the medical consumer industry. If you need more information, I suggest you pay attention to the company's dynamics and be cautious in investment and financial management.

Which stocks should I buy after the medical consumer stocks fall?

After the decline of medical consumer stocks, you can consider buying stocks of other companies in the medical consumer sector, such as:

_ _ Baiyun Mountain: The company's core products include amoxicillin capsules, ceftriaxone sodium for injection, bismuth pectin, omeprazole enteric-coated tablets, tetrandrine tablets, atorvastatin calcium tablets and simvastatin tablets. Baiyun Mountain Banlangen Granule is one of the leading products of the company, and it has been the champion of Banlangen drug sales for ten consecutive years.

_ _ Mindray Medical: The company's core products include in vitro diagnostic products, medical imaging equipment, clinical laboratory analysis systems, ultrasonic instruments and equipment, animal medical equipment, rehabilitation products and medical system software.

_ _ Fan Jian Bio: The company's core products include hemoperfusion related products, biomaterials and biological products.

The possible risks of the above-mentioned stocks include company performance fluctuation and policy risk. And investment needs to be cautious.

Medical consumer stock leading stock

The leading stocks of medical consumer stocks are:

_ _ _ _ _ Wan Tai Biological Company (603392).

_ _ _ _ Changchun High-tech _ _ (00066 1).

_ _ _ _ zhifei Biology _ _ (300 122).

_ _ _ _ _ Opcon _ _(300555)。

_ _ _ _ _ Tiger Medicine _ _ (300347).

_ _ _ _ _ Huada Gene _ _ (300 176).

_ _ _ _ Mindray Medical _ _ (300760).

_ _ _ _ Yifeng Pharmacy _ _ (300937).

_ _ _ _ New Industry _ _ (300839).

_ _ _ _ Lepu Medical _ _ (300003).

_ _ _ _ Wei Lan Medicine _ _ (603889).

_ _ _ _ Wei Xinkang _ _ (603657).

_ _ _ _ Bi Shuiyuan _ _ (000976).

_ _ _ _ _ Huaping shares _ _ _ (300074).

_ _ _ _ Innovative medical care _ _ (002 173).

These are some leading medical consumer stocks. Please note that investment is risky and needs to be cautious.

Will medical consumer stocks go up?

Whether medical consumer stocks will continue to rise in the future is a complex issue, which depends on many factors, such as market trends, company performance, policy environment and so on. Medical consumer stocks generally refer to stocks related to human health, such as medicines, medical devices, medical technology, medical care and so on.

At present, the global medical consumer market is growing, which provides a good market foundation for medical consumer stocks. However, the market is always full of uncertainty. When investing in medical consumer stocks, investors need to conduct in-depth research and analysis on the company's performance, financial situation, industry prospects and other factors.

Generally speaking, the future rise of medical consumer stocks depends on many factors, including but not limited to market demand, industry competition pattern, company operating conditions and so on. Investment decisions need to be made according to individual risk tolerance, investment objectives and market environment. It is suggested that you continue to pay attention to market trends and company reports to obtain more accurate forecasts. Before making any investment decision, it is recommended to consult a professional investment consultant.

This is the end of the introduction of leading stocks in the medical consumption sector.